| 22.81 Delayed Data As of Jun 14 |  -0.79 / -3.35%Today’s Change | 15.92 Today|||52-Week Range 29.44 | +16.73% Year-to-Date |
| Previous close | 23.60 |
| Today’s open | 23.55 |
| Day’s range | 22.77 - 23.68 |
| Volume | 1,202,249 |
| Average volume (3 months) | 1,863,897 |
| Market cap | $4.2B |
| Earnings growth (last year) | +82.28% |
| Earnings growth (this year) | -4.92% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +14.33% |
| P/E ratio | 87.7 |
| Price/Sales | 2.69 |
| Price/Book | 3.65 |
| Today’s change | Today’s % change | |
|---|---|---|
| CBPOChina Biologic Produ... | +1.26 | +1.38% |
| GRFSGrifols SA | -0.29 | -1.48% |
| HCMHutchison China Medi... | -0.74 | -2.74% |
| RGENRepligen Corp | -0.76 | -1.01% |
| Next reporting date | August 5, 2019 |
| EPS forecast (this quarter) | $0.39 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | -$74.2M |
| Net profit margin | -6.14% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Timothy P. Walbert |
Senior VP-Business Operations & Government Affairs Robert W. Metz |
Corporate headquarters Dublin, Dublin |
